News Center
April 29, 2022
Company Spotlight Series: Nizan Stern Braun
- By Variantyx
- Posted in Employee Spotlight Series
I immediately started searching for an external course that would provide me the opportunity to be promoted to the business...
April 22, 2022
Getting to a Lifetime Genetic Textbook for Treating Disease
- By Haim Neerman
- Posted in Other
As a society, how much should be invested in creating a “transformative textbook of medicine, with insights that will give...
February 25, 2022
Jansen’s Story
- By Suzanne and Brent Jones
- Posted in Clinical Education
Edited by Kyle W. Davis, CGC and Marimac Moore In honor of Rare Disease Day 2022, we want to introduce...
February 25, 2022
Company Spotlight Series: Lucy Kaplun
- By Variantyx
- Posted in Employee Spotlight Series
As I reflect back, I don’t feel that this one decision determined my career necessarily. It was actually the exciting...
February 12, 2022
Technology-Driven Precision Medicine Company Variantyx Secures $41.5M in Funding
- By Variantyx
- Posted in Press Releases
Funding Round is Led by New Era Capital Partners and Includes Peregrine Ventures, Robert Bosch Venture Capital, 20/20 HealthCare Partners,...
December 14, 2021
Variantyx Winter Holiday Hours of Operation
- By Variantyx, Inc
- Posted in Other
Valued Customers, We would like to update you on our winter holiday hours of operation: Our offices will be closed...
November 12, 2021
Variantyx and Robert-Bosch Hospital team up to improve personalized oncology treatment
- By STUTTGART
- Posted in Press Releases
STUTTGART, Germany, Nov. 15, 2021 PRNewswire Robert Bosch Venture Capital GmbH, the corporate venture capital company of the Bosch Group, has...
August 31, 2021
ACMG secondary findings updated list for reporting of secondary findings, for medically actionable genes in clinical exome and genome sequencing
- By Variantyx
- Posted in New & Updated Tests
ACMG secondary findings updated list for reporting of secondary findings, for medically actionable genes in clinical exome and genome sequencing. ...
May 11, 2021
Variantyx Expands Into Prenatal, Cancer Testing
- By Variantyx
- Posted in New & Updated Tests
Genomeweb | May 11, 2021 Variantyx, a genetic testing company offering clinical whole-genome sequencing-based assays, is expanding its menu to...
March 15, 2021
Variantyx Secures $20M in Funding for Whole Genome Sequencing Methodology, Advanced Testing Method that Diagnoses Genetic Disorders
- By Variantyx
- Posted in Press Releases
March 15, 2021 Variantyx, a leader in high complexity hereditary disease testing, today announced that they secured $20M in funding...